Autologous stem-cell transplantation in patients with HIV-related lymphoma

Journal of Clinical Oncology

Volumn 27, Issue 13, 2009, Pages 2192-2198

  Balsalobre, Pascual ^a   Díez Martín, José L ^a   Re, Alessandro ^a   Michieli, Mariagrazia ^a   Ribera, José M ^a   Canals, Carmen ^a   Rosselet, Anne ^a   Conde, Eulogio ^a   Varela, Rosario ^a   Cwynarski, Kate ^a   Gabriel, Ian ^a   Genet, Philippe ^a   Guillerm, Gaelle ^a   Allione, Bernardino ^a   Ferrant, Augustin ^a   Biron, Pierre ^a   Espigado, Ildefonso ^a   Serrano, David ^a   Sureda, Anna ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CD34 ANTIGEN; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; RITUXIMAB;

ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BACTERIAL INFECTION; BURKITT LYMPHOMA; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER RESISTANCE; CANCER SURVIVAL; CELL COUNT; CHEMOSENSITIVITY; DISEASE ASSOCIATION; ENGRAFTMENT; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LARGE CELL LYMPHOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MIXED CELLULARITY HODGKIN LYMPHOMA; NEUTROPHIL; NODULAR SCLEROSIS HODGKIN LYMPHOMA; NONHODGKIN LYMPHOMA; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; T CELL LYMPHOMA; THROMBOCYTE; TREATMENT OUTCOME; AUTOTRANSPLANTATION; B CELL LYMPHOMA; CLINICAL TRIAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; RECURRENT DISEASE;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, AIDS-RELATED; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS;

EID: 65549129102     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.18.2683     Document Type: Article

References (46)

1. Frisch M, Biggar RJ, Engels EA, et al: Association of cancer with AIDS-related immunosuppression in adults. JAMA 285:1736-1745, 2001 (Pubitemid 32259908)
2. Levine AM: Acquired immunodeficiency syndrome-related lymphoma: Clinical aspects. Semin Oncol 27:442-453, 2000 (Pubitemid 30626443)
3. Navarro JT, Ribera JM, Oriol A, et al: International prognostic index is the best prognostic factor for survival in patients with AIDS-related non-Hodgkin's lymphoma treated with CHOP: A multivariate study of 46 patients. Haematologica 83:508-513, 1998 (Pubitemid 28331168)
4. Seneviratne L, Espina BM, Nathwani BN, et al: Clinical, immunologic and pathologic correlates of bone marrow involvement in 291 patients with acquired immunodeficiency syndrome-related lymphoma. Blood 98:2358-2363, 2001
5. Kaplan LD, Straus DJ, Testa MA, et al: Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection: National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med 336:1641-1648, 1997
6. Palella FJ Jr, Delaney KM, Moorman AC, et al: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338:853-860, 1998
7. Kirk O, Pedersen C, Cozzi-Lepri A, et al: Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 98:3406-3412, 2001
8. Matthews GV, Bower M, Mandalia S, et al: Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy. Blood 96:2730-2734, 2000 (Pubitemid 30770367)
9. Navarro JT, Ribera JM, Oriol A, et al: Influence of highly active antirretroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicine, vincristine and prednisone. Br J Haematol 112:909-915, 2001 (Pubitemid 32322915)
10. Ratner L, Lee J, Tang S, et al: Chemotherapy for human immunodeficiency virus-associated non- Hodgkin's lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol 19:2171-2178, 2001 (Pubitemid 32366971)
11. Hoffmann C, Wolf E, Fätkenheuer G, et al: Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma. AIDS 17:1521-1529, 2003 (Pubitemid 36900553)
12. Bower M, Gazzard B, Mandalia S, et al: A prognostic index for systemic AIDS-related non- Hodgkin lymphoma treated in the era of highly active antiretroviral therapy. Ann Intern Med 143: 265-273, 2005 (Pubitemid 41134221)
13. Bi J, Espina BM, Tulpule A, et al: High-dose cytosine-arabinoside and cisplatin regimens as salvage therapy for refractory or relapsed AIDS-related non-Hodgkin's lymphoma. J Acquir Immune Defic Syndr 28:416-421, 2001 (Pubitemid 34033191)
14. Spina M, Vaccher E, Juzbasic S, et al: Human immunodeficiency virus-related non-Hodgkin's lymphoma: Activity of infusional cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40 patients. Cancer 92:200-206, 2001 (Pubitemid 32623058)
15. Vose JM, Rizzo DJ, Tao-Wu J, et al: Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission. Biol Blood Marrow Transplant 10:116-127, 2004 (Pubitemid 38145865)
16. Nademanee A, Molina A, O'Donnell MR, et al: Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: International index high and high-intermediate risk group. Blood 90:3844-3852, 1997 (Pubitemid 27484035)
17. Milpied N, Deconinck E, Gaillard F, et al: Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med 350:1287-1295, 2004 (Pubitemid 38375363)
18. Gabarre J, Marcelin AG, Azar N, et al: High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: Results and impact on HIV disease. Haematologica 89:1100-1108, 2004 (Pubitemid 39295481)
19. Krishnan A, Molina A, Zaia J, et al: Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood 105:874-878, 2005 (Pubitemid 40070778)
20. Re A, Cattaneo C, Michieli M, et al: High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol 21:4423-4427, 2003 (Pubitemid 46621820)
21. Serrano D, Carrion R, Balsalobre P, et al: HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation. Exp Hematol 33:487-494, 2005 (Pubitemid 40387632)
22. European Bone Marrow Transplantation Group: MED-AB forms manual. A guide to the completion of the EBMT Med-AB Forms. http://www.ebmt.org/ 4Registry/Registry-docs/MED-AB%20Manual.pdf
23. Klein JP, Rizzo JD, Zhang MJ, et al: Statistical methods for the analysis and presentation of the results of bone marrow transplants: Part I. Unadjusted analysis. Bone Marrow Transplant 28:909-915, 2001 (Pubitemid 33130231)
24. Klein JP, Rizzo JD, Zhang MJ, et al: Statistical methods for the analysis and presentation of the results of bone marrow transplants: Part 2. Regression modeling. Bone Marrow Transplant 28:1001-1011, 2001 (Pubitemid 34030645)
25. Navarro WH, Kaplan LD: AIDS-related lymphoproliferative disease. Blood 107:13-20, 2006
26. Besson C, Goubar A, Gabarre J, et al: Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 98:2339-2344, 2001
27. Herida M, Mary-Krause M, Kaphan R, et al: Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 21:3447-3453, 2003 (Pubitemid 46594077)
28. Biggar RJ, Jaffe ES, Goedert JJ, et al: Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 108:3786-3791, 2006
29. Levine AM: Hodgkin lymphoma: To the HAART of the matter. Blood 108:3630, 2006
30. Little RF, Pittaluga S, Grant N, et al: Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: Impact of antiretroviral therapy suspension and tumor biology. Blood 101:4653-4659, 2003 (Pubitemid 36857717)
31. Sparano JA, Lee S, Chen MG, et al: Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non- Hodgkin's lymphoma: An Eastern Cooperative Oncology Group Trial. J Clin Oncol 22:1491-1500, 2004 (Pubitemid 41103632)
32. Miralles P, Berenguer J, Ribera JM, et al: Prognosis of AIDS-related systemic non-Hodgkin lymphoma treated with chemotherapy and highly active antiretroviral therapy depends exclusively on tumor-related factors. J Acquir Immune Defic Syndr 44:167-173, 2007 (Pubitemid 46292219)
33. Kaplan LD, Lee JY, Ambinder RF, et al: Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non- Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood 106:1538-1543, 2005
34. Spina M, Jaeger U, Sparano JA, et al: Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: Pooled results from 3 phase 2 trials. Blood 105:1891-1897, 2005
35. Ribera JM, Oriol A, Morgades M, et al: Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: Results of a phase II trial. Br J Haematol 140:411-419, 2008
36. Gabarre J, Azar N, Autran B, et al: High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma. Lancet 355:1071-1072, 2000 (Pubitemid 30162812)
37. Re A, Michieli MG, Cataneo C, et al: High dose therapy and autologous peripheral blood stem cell transplantation as salvage therapy for HIV-associated lymphoma: Results of the GICAT study. Blood 110: 15a, 2007 (abstr 23)
38. Serrano D, Balsalobre P, Carrion R, et al: Comparative study of autologous stem cell transplant (ASCT) in HIV-1 positive (HIV+) on HAART and HIV-1 negative (HIV-) non hodgkin lymphoma (NHL) patients. Blood 108:872a, 2006 (abstr 3063)
39. Balsalobre P, Serrano D, Carrion R, et al: Autologous stem cell transplant (ASCT) in HIV-1 positive (HIV+) Hodgkin lymphoma (HL) patients in the HAART era: Are clinical results comparable to those in HIV-1 negative (HIV-) HL patients? Blood 108:458b, 2006 (abstr 5450)
40. Oriol A, Ribera JM, Bergua J, et al: High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: Comparison of results in human immunodeficiency virus-infected and noninfected patients. Cancer 113:117-125, 2008 (Pubitemid 351976392)
41. Nademanee A, Forman SJ: Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B. Semin Hematol 43:240-250, 2006 (Pubitemid 44486318)
42. Sureda A: Autologous and allogeneic stem cell transplantation in Hodgkin's lymphoma. Hematol Oncol Clin North Am 21:943-960, 2007 (Pubitemid 47484144)
43. Schaefer-Cutillo J, Friedberg JW, Fisher RI: Novel concepts in radioimmunotherapy for non-Hodgkin's lymphoma. Oncology (Williston Park) 21:203-212, 2007 (Pubitemid 46331734)
44. Diez-Martin JL, Balsalobre P, Re A, et al: Comparable survival between HIV+ and HIV- Hodgkins lymphoma (HL) and non-Hodgkins lymphoma (NHL) patients undergoing an autologous peripheral blood stem cell transplantation (ASCT). A retrospective analysis of the EBMT Lymphoma Working Party. Blood 110:15a, 2007 (abstr 24)
45. Resino S, Pérez A, Seoane E, et al: Immune reconstitution after autologous peripheral blood stem cell transplantation in HIV-infected patients: Might be better than expected? AIDS Res Hum Retroviruses 23:543-548, 2007
46. Rizzo JD, Wingard JR, Tichelli A: Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: Joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT). Bone Marrow Transplant 37:249-261, 2006